Related Experiment Video
Updated: Jul 16, 2026
04:30
Stimulated Single Fiber Electromyography (SFEMG) for Assessing Neuromuscular Junction Transmission in Rodent Models
Published on: March 8, 2024
A temporary decrease in twitch response during reversal of rocuronium-induced muscle relaxation with a small dose of
Douglas J Eleveld1, Karel Kuizenga, Johannes H Proost
1Research Group for Experimental Anesthesiology and Clinical Pharmacology, University Medical Center, University of Groningen, Groningen, The Netherlands. d.j.eleveld@anest.umcg.nl
Anesthesia and Analgesia
|February 22, 2007
Summary
A temporary decrease in muscle relaxation, termed rebound, can occur after sugammadex reversal of rocuronium. Sufficiently high sugammadex doses prevent this rebound effect.
Area of Science:
- Anesthesiology
- Pharmacology
- Clinical Medicine
Background:
- Rocuronium is a neuromuscular blocking agent used in anesthesia.
- Sugammadex is a reversal agent for rocuronium-induced neuromuscular blockade.
- A transient decrease in train-of-four (TOF) response, termed muscle relaxation rebound, was observed post-sugammadex administration.
Observation:
- A case study detailed a temporary decrease in TOF response after a low dose of sugammadex (0.5 mg/kg) given 42 minutes after rocuronium (0.9 mg/kg).
- Despite the rebound, the patient exhibited a TOF ratio >0.9 and recovered without residual neuromuscular weakness.
Findings:
- A pharmacokinetic-pharmacodynamic model of rocuronium and sugammadex interaction was developed and fitted to patient TOF data.
- Model simulations suggest muscle relaxation rebound occurs within a critical range of sugammadex doses.
- The rebound phenomenon is hypothesized to result from insufficient sugammadex for peripheral rocuronium redistribution.
Implications:
- Higher sugammadex doses effectively eliminate the risk of muscle relaxation rebound.
- This finding emphasizes the importance of appropriate sugammadex dosing for safe reversal of neuromuscular blockade.
- Understanding the dynamics of sugammadex-rocuronium interaction is crucial for preventing postoperative residual neuromuscular blockade.
Related Concept Videos
01:21Skeletal Muscle Relaxants: Adverse Effects
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
01:28Classification of Skeletal Muscle Relaxants
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
01:31Skeletal Muscle Relaxants: Therapeutic Uses
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
01:28Depolarizing Blockers: Mechanism of Action
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
01:27Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
01:29Relaxation of Skeletal Muscles
The period of muscle contraction primarily influences the duration of stimulation at the neuromuscular junction (NMJ), the presence of free calcium ions in the sarcoplasm, and the availability of energy or ATP to support contractions.
When an action potential reaches the axon terminal, it depolarizes the membrane and opens voltage-gated sodium channels. Sodium ions enter the cell, further depolarizing the presynaptic membrane. This depolarization causes voltage-gated calcium channels to open.
When an action potential reaches the axon terminal, it depolarizes the membrane and opens voltage-gated sodium channels. Sodium ions enter the cell, further depolarizing the presynaptic membrane. This depolarization causes voltage-gated calcium channels to open.